Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya(Institute of Cancer Research), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Susan Tomkins(University Hospitals Bristol NHS Foundation Trust), B. Rajashanker, J. Samuel Pope(Institute of Cancer Research), Helen Hanson(University of Exeter), Christos Mikropoulos(Institute of Cancer Research), Sarah Thomas(King's College London), Anthony Chamberlain(Institute of Cancer Research), Sarah Benafif(Institute of Cancer Research), Lauren Limb(Northwick Park Hospital), Alexander Dias(Institute of Cancer Research), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Dow‐Mu Koh(Royal Marsden NHS Foundation Trust), Lucy Side(Unknown), David Gallagher(Mater Misericordiae University Hospital), Fiona J. Gilbert(University of Cambridge), R. Gunapala(Royal Marsden NHS Foundation Trust), Julian Barwell(London North West Healthcare NHS Trust), Susan Shanley(Royal Marsden NHS Foundation Trust), Martin O. Leach(Engineering and Physical Sciences Research Council), Vicki Wiles(University of Cambridge), Emma Killick(Institute of Cancer Research), D. Gareth Evans(Manchester Academic Health Science Centre), Lisa Walker(Oxford University Hospitals NHS Trust), Jeanette Rothwell(Manchester Academic Health Science Centre), Richard W. Whitehousé, S.A. Sohaib(Royal Marsden NHS Foundation Trust), Natalie Taylor(Royal Marsden NHS Foundation Trust), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Diana Eccles(Princess Anne Hospital), Jackie Cook(Sheffield Children's Hospital)
Cited by 68
Related Papers
Nonrigid registration using free-form deformations: application to breast MR images
|IEEE Transactions on Medical Imaging|1999|5.3k
International evaluation of an AI system for breast cancer screening
|Nature|2020|3.1k
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k